LISA TRACKER® monitoring kits have been referenced by MSD France in contracts to supply Remicade® Croissy-Beaubourg, December 21, 2017, 6:00pm CET – THERADIAG (ISIN code: FR0004197747, Ticker: ALTER, eligible for PEA-PME equity savings plans) a company specialized in…
Croissy-Beaubourg and Montpellier, December 19, 2017, 6:00pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, eligible for PEA-PME equity savings plans) a company specialized in in vitro diagnostics and theranostics, today announced the discontinuation of its Prestizia research…
Lisa Tracker monitoring kits will be provided with the Flixabi® biosimilar Croissy-Beaubourg and Montpellier, November 14, 2017, 6:00pm CET – THERADIAG (ISIN code: FR0004197747, Ticker: ALTER) a company specialized in in vitro diagnostics and theranostics, is today…